Sirithepphavanh S. Oliver, NP
Nurse Practitioner Obstetrics & Gynecology
Hospital of University of Pennsylvania
Philadelphia, PA

Sirithepphavanh (Siri) Oliver, NP is a Clinical Nurse Manager and Gynecologic Oncology Lead Nurse Practitioner at the University of Pennsylvania Abramson Cancer Center in Philadelphia, Pennsylvania. Ms. Oliver has extensive clinical experience in Gynecologic Oncology and was previously affiliated with the Karmanos Cancer Institute, the University of Washington Seattle Cancer Care Alliance, and Arizona Oncology.

Ms. Oliver earned her Bachelor of Science in Nursing in 2006 from Brigham Young University. She completed her Doctor of Nursing Practice, Acute Care Nurse Practitioner degree at the University of Utah in 2011. She is a current member of the American Association of Nurse Practitioners, Sigma Theta Tau International, and the American Nurses Association. Ms. Oliver also serves as a University of Pennsylvania Cancer Center and Women’s Health EPIC Shared Governance Department Representative and is a University of Pennsylvania Innovation Grant Participant as a Group Member for two projects: TOGETHER Care and Gyn Onc Access.

Mary B. Welch, MS, FNP, AOCN
GYN Oncology Nurse Practitioner/ Nurse Navigator
MemorialCare Long Beach Medical Center
Long Beach, CA
 

Mary B. Welch, MS, FNP, AOCN, is a GYN Oncology Nurse Practitioner/ Nurse Navigator with MemorialCare Long Beach Medical Center in Long Beach, CA. Ms. Welch has been published in Oncology Nursing Forum and has presented over 150 oncology speaker programs to a wide range of audiences, ranging from students to nurses to support groups. Ms. Welch earned both her B.S. and Master’s degree in Nursing from Georgetown University in Washington, D.C. In addition, Ms. Welch is an Advanced Oncology Certified Nurse Practitioner.

It is the policy of Creative Educational Concepts, LLC, (CEC) to ensure independence, balance, objectivity, and scientific rigor and integrity in all their CME/CE activities. Activity planners, faculty, peer reviewers, and CEC staff must disclose to the participants any relationships with ineligible entities whose products or devices may be mentioned in this CE activity, or with the commercial supporter of this CE activity. An ineligible entity is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Financial relationships may include research grants, consultant fees, travel, advisory boards, consultancy, speakers’ bureaus, other benefits, or having a self-managed equity interest in a company.

CEC has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Planner/Faculty:
Sirithepphavanh S. Oliver, NP–has disclosed that she is on the Speakers Bureau for GlaxoSmithKline.

Faculty:
Mary B. Welch, MS, FNP, AOCN–has no relevant financial relationships to disclose in relation to the content of this activity.

Peer Reviewer:
Julie Mary George, NP–has no relevant financial relationships to disclose in relation to the content of this activity.

CEC Staff:
Tina L. Trieu, PharmD–has no relevant financial relationships to disclose in relation to the content of this activity.
Jessica Hall–has no relevant financial relationships to disclose in relation to the content of this activity.

Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CEC, the faculty, and any commercial supporter of this activity do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.